自体血小板与细胞外囊泡富集血浆治疗慢性术后颞骨腔炎症的随机对照临床试验数据表8

数据集获取（Figshare）

• 源站标题：Table_8_Autologous Platelet- and Extracellular Vesicle-Rich Plasma Is an Effective Treatment Modality for Chronic Postoperative Temporal Bone Cavity Inflammation: Randomized Controlled Clinical Trial.DOCX
• DOI：10.3389/fbioe.2021.677541.s009
• 发布日期：2021-07-07
• 文件数：1 个
• 文件总体积：681.28 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Table_8_Autologous_Platelet-_and_Extracellular_Vesicle-Rich_Plasma_Is_an_Effective_Treatment_Modality_for_Chronic_Postoperative_Temporal_Bone_Cavity_Inflammation_Randomized_Controlled_Clinical_Trial_DOCX/14923755

命令行下载

curl -L -o "Table_8_Autologous Platelet- and Extracellular Vesicle-Rich Plasma Is an Effective Treatment Modality for Chronic Postoperative Temporal Bone Cavity I.DOCX" "https://ndownloader.figshare.com/files/28736616"

文件清单

• Table_8_Autologous Platelet- and Extracellular Vesicle-Rich Plasma Is an Effective Treatment Modality for Chronic Postoperative Temporal Bone Cavity I.DOCX（681.28 KB）

文件总体积 681.28 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

PurposeTo determine the efficacy of autologous platelet- and extracellular vesicle-rich plasma (PVRP) to treat chronic postoperative temporal bone cavity inflammation (CPTBCI) after exhausting surgical and standard conservative therapies.
Materials and MethodsPatients were randomly allocated to treatment with PVRP (PVRP group) or standard conservative methods (control group) in a setting of four once-monthly checkups and subsequent follow-up. The treatment outcome was measured with the Chronic Otitis Media Questionnaire-12 (COMQ-12), CPTBCI focus surface area, and CPTBCI symptom-free time after the fourth checkup.
ResultsEleven patients from each group completed the trial; 95% of patients suffered from chronically discharging mastoid cavity (the type of CPTBCI). Within four checkups, the COMQ-12 score decreased statistically significantly in the PVRP group (p 0.05) in the PVRP group. No statistically significant differences in CPTBCI foci surface area were detected between checkups in the control group (p = 0.152). Nine patients from the PVRP group and three patients from the control group were CPTBCI symptom-free at the fourth checkup. The median symptom-free time was 9.2 months (95% CI [7.4, 11.9]) in the PVRP group. Cumulatively, 49% of patients in the PVRP group remained CPTBCI symptom-free for 12.7 months after the fourth checkup.
ConclusionAutologous PVRP represents a novel additional and successful treatment modality for a chronically discharging radical mastoid cavity when the surgical and standard conservative treatment methods have been exhausted.
Trial Numberhttps://clinicaltrials.gov (NCT04281901).

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fbioe.2021.677541.s009（source: https://frontiersin.figshare.com/articles/dataset/Table_8_Autologous_Platelet-_and_Extracellular_Vesicle-Rich_Plasma_Is_an_Effective_Treatment_Modality_for_Chronic_Postoperative_Temporal_Bone_Cavity_Inflammation_Randomized_Controlled_Clinical_Trial_DOCX/14923755）。